Hip fracture
Conditions
Interventions
1:Oral calcium carbonate D3 tablets treatment
2:Oral placebo
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
75 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Aged >=75 years old; 2. Clinical and imaging diagnosis of hip fracture, including femoral neck fracture and intertrochanteric fracture; 3. treated in our hospital and regularly followed up for > 6 months, during the follow-up period The fracture healing was checked and the data was kept intact; 4. The patient signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with a history of hip fracture; (2) with other fractures; (3) with diabetes, thyroid disease, endocrine system diseases, osteoarthrosis and other diseases affecting bone metabolism or recent taking calcium, diuretic, glucocorticoids Heparin and other drugs that may affect bone metabolism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Imaging evaluation;K-M Survival Analysis;Hip bone density;Full load-bearing time;SF-36 Score;Complications; | — |
Countries
China
Contacts
Public ContactFeng Shuo
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed